Amorphous ritonavir and process for its preparation

This Application concerns the use of Form II crystalline ritonavir as a pharmaceutical agent, as well as methods of preparing pharmaceutical compositions, which methods employ Form II crystalline ritonavir. The Application further concerns methods for obtaining Form I crystalline ritonavir, which me...

Full description

Saved in:
Bibliographic Details
Main Authors BAUER JOHN F, NARAYANAN BIKSHANDARKOIL A, ALLEN KIMBERLY A, SPIWEK HARRY O, SALEKI-GERHARDT AZITA, BAUER PHILIP E, BURKAR SANJAY R, PATEL KETAN
Format Patent
LanguageEnglish
Hungarian
Published 28.09.2015
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:This Application concerns the use of Form II crystalline ritonavir as a pharmaceutical agent, as well as methods of preparing pharmaceutical compositions, which methods employ Form II crystalline ritonavir. The Application further concerns methods for obtaining Form I crystalline ritonavir, which methods employ Form II crystalline ritonavir.
Bibliography:Application Number: HUP0800266